Wihersaari, Lauri
Ashton, Nicholas J.
Reinikainen, Matti
Jakkula, Pekka
Pettilä, Ville
Hästbacka, Johanna
Tiainen, Marjaana
Loisa, Pekka
Friberg, Hans
Cronberg, Tobias
Blennow, Kaj
Zetterberg, Henrik
Skrifvars, Markus B. http://orcid.org/0000-0002-0341-0262
Laru-Sompa, Raili
Pulkkinen, Anni
Reilama, Mikko
Tolmunen, Sinikka
Bäcklund, Minna
Heinonen, Jonna
Hästbacka, Johanna
Jakkula, Pekka
Lundbom, Nina
Norrgård, Marcus
Okkonen, Marjatta
Pettilä, Ville
Skrifvars, Markus B.
Suhonen, Tarja
Tiainen, Marjaana
Tikka, Tuukka
Timonen, Marjut
Toppila, Jussi
Valkonen, Miia
Wilkman, Erika
Hult, Teemu
Oksanen, Tuomas
Bendel, Stepani
Halonen, Elina
Rahikainen, Sari
Rissanen, Saija
Vaskelainen, Eija
Eiserbeck, Tanja
Heino, Sirkku
Jyrkönen, Helena
Reinikainen, Matti
Räsänen, Johanna
Surakka, Tero
Koskue, Talvikki
Kujala, Petteri
Loisa, Pekka
Lähde, Marika
Kalliomäki, Jari
Karlsson, Sari
Kukkurainen, Atte
Varila, Simo
,
Funding for this research was provided by:
Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH2018227)
Stiftelsen Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Minne (2018, 2019)
Medicinska Understödsföreningen Liv och Hälsa (2018, 2019)
Suomen Anestesiologiyhdistys
Orionin Tutkimussäätiö
Svenska Kulturfonden
Swedish Reserach Council (#2017-00915)
The Swedish Alzheimer Foundation (#AF-742881)
Hjärnfonden (#FO2017-0243)
Swedish Research Council (#2018-02532)
European Research Council (#681712)
Swedish State Support for Clinical Research (#ALFGBG-720931)
Alzheimer Drug Discovery Foundation ((#201809-2016862)
the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986)
European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236)
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 12 May 2020
Accepted: 14 August 2020
First Online: 27 August 2020
Compliance with ethical standards
:
: Markus Skrifvars reports speakers’ fees and travel grants from BARD Medical (Ireland) and a research grant from GE Healthcare. Kaj Blennow has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. Henrik Zetterberg has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program.
: The protocol of the COMACARE study has been previously published [CitationRef removed].